Evidence map›Paper›PMID 36440912›Full record

ArticleBioinformatics (Oxford, England)2023

varAmpliCNV: analyzing variance of amplicons to detect CNVs in targeted NGS data.

Ajay Anand Kumar, Bart Loeys, Gerarda Van De Beek, Nils Peeters, Wim Wuyts, Lut Van Laer, Geert Vandeweyer, Maaike Alaerts

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. GermlineCurrent oncology (Toronto, Ont.) · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ajay Anand KumarCenter of Medical Genetics, University of Antwerp/Antwerp University Hospital, Antwerp (Edegem) 2650, Belgium.ORCID 0000-0002-0897-055X
Bart LoeysCenter of Medical Genetics, University of Antwerp/Antwerp University Hospital, Antwerp (Edegem) 2650, Belgium.
Gerarda Van De BeekCenter of Medical Genetics, University of Antwerp/Antwerp University Hospital, Antwerp (Edegem) 2650, Belgium.
Nils PeetersCenter of Medical Genetics, University of Antwerp/Antwerp University Hospital, Antwerp (Edegem) 2650, Belgium.
Wim WuytsCenter of Medical Genetics, University of Antwerp/Antwerp University Hospital, Antwerp (Edegem) 2650, Belgium.
Lut Van LaerCenter of Medical Genetics, University of Antwerp/Antwerp University Hospital, Antwerp (Edegem) 2650, Belgium.
Geert VandeweyerCenter of Medical Genetics, University of Antwerp/Antwerp University Hospital, Antwerp (Edegem) 2650, Belgium.
Maaike AlaertsCenter of Medical Genetics, University of Antwerp/Antwerp University Hospital, Antwerp (Edegem) 2650, Belgium.

Funding

Dutch Heart Foundation 2013T093European Research CouncilResearch Foundation-FlandersResearch Foundation-Flanders G.0356.17University of Antwerp
6 · The paper itself

Abstract

motivationComputational identification of copy number variants (CNVs) in sequencing data is a challenging task. Existing CNV-detection methods account for various sources of variation and perform different normalization strategies. However, their applicability and predictions are restricted to specific enrichment protocols. Here, we introduce a novel tool named varAmpliCNV, specifically designed for CNV-detection in amplicon-based targeted resequencing data (Haloplex™ enrichment protocol) in the absence of matched controls. VarAmpliCNV utilizes principal component analysis (PCA) and/or metric dimensional scaling (MDS) to control variances of amplicon associated read counts enabling effective detection of CNV signals.

resultsPerformance of VarAmpliCNV was compared against three existing methods (ConVaDING, ONCOCNV and DECoN) on data of 167 samples run with an aortic aneurysm gene panel (n = 30), including 9 positive control samples. Additionally, we validated the performance on a large deafness gene panel (n = 145) run on 138 samples, containing 4 positive controls. VarAmpliCNV achieved higher sensitivity (100%) and specificity (99.78%) in comparison to competing methods. In addition, unsupervised clustering of CNV segments and visualization plots of amplicons spanning these regions are included as a downstream strategy to filter out false positives. AVAILABILITY AND IMPLEMENTATION: The tool is freely available through galaxy toolshed and at: https://hub.docker.com/r/cmgantwerpen/varamplicnv. Supplementary Data File S1: https://tinyurl.com/2yzswyhh; Supplementary Data File S2: https://tinyurl.com/ycyf2fb4. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

AlgorithmsDNA Copy Number VariationsHigh-Throughput Nucleotide SequencingSequence Analysis, DNA

Identifiers

PMID36440912
PMCPMC9805572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.